The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis

Launched by UNIVERSITY OF AARHUS · Jul 1, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how common two sexually transmitted infections, Chlamydia and Gonorrhoea, are in people who have symptoms of haemorrhagic proctosigmoiditis—a type of inflammation in the lower part of the bowel that causes bleeding and discomfort. Because these infections can cause similar symptoms to other bowel diseases, doctors want to better understand how often these infections might be the cause or a contributing factor. The study will involve patients who are either newly diagnosed or have recurring symptoms and who are having a lower bowel examination called an endoscopy.

If you join the study, during your endoscopy, a small swab will be taken from the inflamed area to test for Chlamydia and Gonorrhoea using a quick laboratory test. If the swab can’t be taken during the procedure, it will be done at a follow-up visit. If you test positive, you will be offered treatment for the infection. Your current bowel treatment might be paused temporarily if it is safe to do so while you receive treatment for the infection. The study will also keep track of how your symptoms change over time and whether treating these infections helps improve your condition. This study is open to all patients with suspected haemorrhagic proctosigmoiditis who agree to have the swab taken during their examination.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients suspected of haemorrhagic proctosigmoiditis with either newly diagnosed or recurrent disease who undergo lower endoscopy
• Exclusion Criteria:
• • Patients who does not accept the swap to be taken